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Abstract 
We have used double in situ hybridization to examine the cellular localization of 
5-HT2C receptor mRNA in relation to serotonergic and GABAergic neurons in the 
anterior raphe nuclei of the rat. In the dorsal and median raphe nuclei 5-HT2C receptor 
mRNA was not detected in serotonergic cells identified as those expressing serotonin 
(5-HT) transporter mRNA. In contrast, 5-HT2C receptor mRNA was found in most 
GABAergic cells, recognized by the presence of glutamic acid decarboxylase mRNA. 
Such 5-HT2C receptor-positive GABAergic neurons were mainly located in the 
intermediolateral and lateral portions of the dorsal raphe and lateral part of the median 
raphe. The present data give anatomical support to a previous hypothesis that proposed 
a negative-feedback loop involving reciprocal connections between GABAergic 
interneurons bearing 5-HT2A/2C receptors and 5-HT neurons in the dorsal raphe and 
surrounding areas. According to this model, the excitation of GABAergic interneurons 
through these 5-HT2C (and also 5-HT2A) receptors would result in the suppression of 5-
HT cell firing. 
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1. Introduction 
Serotonin (5-hydroxytryptamine; 5-HT) is a neurotransmitter involved in the control of 
a variety of functions, such as mood, appetite or sleep-wake cycle (Leibowitz and 
Alexander, 1998; Barnes and Sharp, 1999). Alterations in serotonergic 
neurotransmission have been related to several neurodegenerative and psychiatric 
disorders such as Alzheimer’s disease (Dewar et al., 1990), depression (Gross-Isseroff 
et al., 1990b) and schizophrenia (Burnet et al., 1996) as well as to normal aging (Gross-
Isseroff et al., 1990a). The physiological and pharmacological effects of 5-HT and 
serotonergic drugs are mediated by multiple receptor subtypes that have been classified 
into seven subfamilies (5-HT1-5-HT7) (Hoyer et al., 1994) and which are differentially 
distributed in the CNS (Palacios et al., 1990; Radja et al., 1991; Mengod et al., 1996). 
The 5-HT2 receptor family comprises three subtypes: 5-HT2A, 5-HT2B and 5-HT2C. They 
share similarities in their molecular structure, pharmacology and signal transduction 
pathways (Hoyer et al., 1994; Barnes and Sharp, 1999). The 5-HT2C receptor (formerly 
named 5-HT1C) was initially described in porcine choroid plexus (Pazos et al., 1984) and 
was soon cloned thereafter (Julius et al., 1988). Its anatomical distribution has been 
studied in rat brain using radioligand binding autoradiography, in situ hybridization, and 
immunohistochemistry (Pazos and Palacios, 1985; Hoffman and Mezey, 1989; 
Molineaux et al., 1989; Mengod et al., 1990; Pompeiano et al., 1994; Abramowski et al., 
1995; Wright et al., 1995; Eberle-Wang et al., 1997; Clemett et al., 2000). These studies 
have shown the presence of 5-HT2C receptors in the raphe nuclei and surrounding 
areas.  
The finding of 5-HT2C-immunoreactive cells in the raphe nuclei has let to the proposal 
that some 5-HT neurons might express these receptors (Clemett et al., 2000). In 
contrast, electrophysiological data rather suggest that 5-HT2C receptors are located on 
local GABAergic neurons, inside or close to the dorsal raphe (DR) (Liu et al., 2000), 
being part of a local negative-feedback circuit which would involve reciprocal 
connections between GABAergic and 5-HT neurons. This model has been proposed to 
explain the increases in the frequency of inhibitory postsynaptic currents (IPSCs) 
induced by 5-HT and the 5-HT2A/2C agonist DOI (1-(2,5-dimethoxy-4-iodophenyl-2-
aminopropane) when applied to rat brain slices containing the DR.  
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The purpose of the present study was to determine whether 5-HT2C receptors in the 
dorsal raphe (DR) and median raphe (MnR) nuclei are expressed by serotonergic, 
GABAergic neurons, or both. Thus, we have used double-label in situ hybridization 
histochemistry in order to simultaneously visualize 5-HT2C receptor mRNA and 
serotonergic and GABAergic cell markers, 5-HT transporter (5-HTT) mRNA and glutamic 
acid decarboxylase (GAD) mRNA, respectively.  
 
2. Materials and methods 
2.1. Specimens 
Adult male Wistar rats (n=25) (200-250 g b.w.) were purchased from Iffa Credo (Lyon, 
France). Animal care followed the Spanish legislation on “Protection of animals used in 
experimental and other scientific purposes” in agreement with European regulations 
(O.J. of EC L358/1 18/12/1986). The animals were kept in a controlled environment 
(12-hours light-dark circle and 22±2°C), with free access to food and water. The animals 
were killed by decapitation, the brains rapidly removed, frozen on dry ice and stored at 
-20ºC. Tissue sections, 14 µm thick, were cut using a microtome-cryostat (HM500 OM, 
Microm, Walldorf, Germany), thaw-mounted onto slides coated with APTS 
(3-aminopropyltriethoxysilane, Sigma, St Louis, USA) and kept at –20ºC until use. 
 
2.2. 5,7-Dihydroxytryptamine lesions 
Forty-five minutes before 5,7-dihydroxytryptamine (5,7-DHT) administration, rats 
(n=4) were pretreated with desipramine (25 mg kg-1, i.p.) (ICN Biomedicals Inc., Aurora, 
Ohio, USA) in order to prevent uptake of the toxin by noradrenaline neurons. The 
animals were then anesthetized with chloral hydrate (350 mg kg-1) and placed in a 
stereotaxic frame. Each rat received an injection of freshly prepared solution of 420 µg 
5,7-DHT creatinine sulphate (equivalent to 200 µg of 5,7-DHT base) (ICN Biomedicals 
Inc.) in 20 µl of 0.1% ascorbic acid in saline into the lateral ventricle at coordinates: AP -
0.8, ML -1.4, DV –4.2 mm using a Hamilton syringe. Sham operated animals (n=4) were 
also pretreated with desipramine and received an i.c.v. injection of vehicle (20 µl of 0.1% 
ascorbic acid in saline) at the same stereotaxic coordinates. The animals were allowed 
to survive for 14 days, and then they were killed and the brains processed as described 
above.  
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2.3. Hybridization probes 
The oligodeoxyribonucleotide probes used were complementary to the following 
bases: 1100-1147 of the rat 5-HT2C receptor cDNA (Genbank acc. no. U35315); 
305-352 and 865-912 of the rat 5-HTT cDNA (Genbank acc. no. M79450); 191-235 of 
the rat GAD67 cDNA (Genbank acc. no. M34445) were synthesized on a 380 Applied 
Biosystems DNA synthesizer (Foster City Biosystem, Foster City, USA) and purified on 
a 20% polyacrylamide / 8 M urea preparative sequencing gel.  
Oligonucleotides were labeled either with 33P or with digoxigenin (Dig). For the 
radioactive method, the oligonucleotides (2 pmol) were 3’-end-labeled with [33P]-dATP 
(>2500 Ci/mmol; DuPont-NEN, Boston, USA) using terminal 
deoxynucleotidyltransferase (Roche Diagnostics GmbH, Mannheim, Germany), purified 
by centrifugation using QIAquick Nucleotide Removal Kit (QIAGEN GmbH, Hilden, 
Germany). Alternatively, for the non-radioactive method, 100 pmol of oligonucleotide 
were labeled by 3’-end tailing with the same enzyme and Dig-11-dUTP (Roche 
Diagnostics GmbH) according to a previously described procedure (Schmitz et al., 
1991). Dig-labeled oligonucleotides were purified by ethanol precipitation. 
 
2.4. In situ hybridization histochemistry procedure 
The protocols for single- and double-label in situ hybridization were based on 
previously described procedures (Tomiyama et al., 1997; Landry et al., 2000) and have 
been published elsewhere (Serrats et al., 2003a). Frozen tissue sections were first 
brought to room temperature, fixed for 20 min at 4ºC in 4% paraformaldehyde in 
phosphate-buffered saline (1x PBS: 8 mM Na2HPO4, 1.4 mM KH2PO4, 136 mM NaCl, 
2.6 mM KCl), washed for 5 min in 3x PBS at rt, twice for 5 min in 1x PBS, and incubated 
for 2 min at 21ºC in a fresh solution of predigested pronase (Calbiochem, San Diego, 
USA) at a final concentration of 24 U/ml in 50 mM Tris-HCl pH 7.5, 5 mM EDTA. The 
enzymatic activity was stopped by immersion for 30 sec in 2 mg/ml glycine in 1x PBS. 
Tissues were finally rinsed in 1x PBS and dehydrated through a graded series of 
ethanol. 
For hybridization, the radioactively labeled and/or the non-radioactively labeled 
probes were dissolved in a solution containing 50% formamide, 4x SSC (1x SSC: 150 
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mM NaCl, 15 mM sodium citrate), 1x Denhardt’s solution (0.02% Ficoll, 0.02% 
polyvinylpyrrolidone, 0.02% bovine serum albumine), 10% dextran sulphate, 1% 
sarkosyl, 20 mM phosphate buffer pH 7.0, 250 µg/ml yeast tRNA and 500 µg/ml salmon 
sperm DNA. The final concentrations of radioactive and Dig-labeled probes in the 
hybridization buffer were in the same range (approximately 1.5 nM). Tissue sections 
were covered with hybridization buffer containing the labeled probe(s), overlaid with 
Nescofilm coverslips (Bando Chemical Ind, Kobe, Japan) and incubated overnight at 
42ºC in humid boxes. The sections were then washed four times (45 min each) in a 
buffer containing 0.6M NaCl and 10 mM Tris (pH 7.5) at 60ºC. 
 
2.5. Development of radioactive and non-radioactive hybridization signal 
The slides that had been hybridized only with 33P-labeled probes were directly 
dehydrated through ethanol and allowed to air-dry. In parallel, sections hybridized with 
Dig-labeled probe(s) were treated as described by Landry et al. (2000). Thus, after 
washing, the slides were immersed for 30 min in a buffer containing 0.1 M Tris HCl pH 
7.5, 1 M NaCl, 2mM MgCl2 and 0.5% bovine serum albumin (Sigma) and incubated 
overnight at 4ºC in the same solution with alkaline-phosphate-conjugated anti-
digoxigenin-F(ab) fragments (1:5000; Roche Diagnostics GmbH). Afterwards, they were 
washed three times (10 min each) in the same buffer (without antibody), and twice in an 
alkaline buffer containing 0.1 M Tris HCl pH 9.5, 0.1 M NaCl, and 5 mM MgCl2. Alkaline 
phosphatase activity was developed by incubating the sections overnight with 330 µg/ml 
nitroblue tetrazolium and 165 µg/ml bromochloroindolyl phosphate (Gibco BRL, 
Gaithersburg, USA) in alkaline buffer. The enzymatic reaction was stopped by extensive 
rinsings in the alkaline buffer supplemented with 1 mM EDTA. The sections were then 
briefly dipped in 70% and 100% ethanol and air-dried.  
Sections incubated with radioactive probes (alone or in combination with Dig-labeled 
oligonucleotides) were dipped into Ilford K5 nuclear emulsion (Ilford, Mobberly, UK) 
diluted 1:1 with distilled water. The sections were exposed in the dark at 4°C for 1 week 
in the case of GAD mRNA or 6 weeks in the case of 5-HT2C receptor mRNA, and finally 
developed in Kodak D19 (Kodak, Rochester, USA) for 5 min, and fixed in Ilford Hypam 
fixer (Ilford). 
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For film autoradiography, some hybridized sections were exposed to Biomax-MR 
(Kodak) films for 2-4 weeks at –70ºC with intensifying screens. Consecutive sections 
were stained with thionin for anatomical reference.  
 
2.6. Specificity of the probes 
The specificity of the probes has been previously established and published 
elsewhere (Pompeiano et al., 1994; Serrats et al., 2003a). The control experiments 
performed included: 1) determination of the thermo-stability of hybrids obtained with 
every probe, 2) blockade of the hybridization signal by competition of the labeled probe 
with 50-fold excess of the same unlabeled oligonucleotide, 3) for each mRNA species at 
least two different oligonucleotide probes were assayed separately, and hybridization 
signal was considered specific only when the regional and cellular labeling obtained with 
both probes independently was identical, 4) to assure the specificity of the 
non-radioactive hybridization signal it was compared to that obtained with the same 
probes radioactively labeled.  
 
2.7. Analysis of the results 
Tissue sections were examined and photographed under bright- and dark-field 
illumination in a Wild 420 macroscope (Leica, Heerbrugg, Germany), in a Nikon Eclipse 
E1000 microscope (Nikon, Tokyo, Japan) and in an Axioplan Zeiss microscope (Carl 
Zeiss, Oberkochen, Germany). Hybridization signal obtained with non-radioactive 
oligonucleotides (5-HTT mRNA and GAD mRNA probes) was identified as a dark 
staining (alkaline phosphatase reaction product) surrounding or covering cellular nuclei. 
Radioactive hybridization signal (GAD mRNA and 5-HT2C receptor mRNA) was 
considered positive when accumulations of silver grains over cell profiles were at least 
three-fold higher than average background.  
In double in situ hybridization experiments, single- and double-labeled cells were 
counted in emulsion-dipped tissue sections from 11 animals (3 control rats and 8 rats 
from lesion studies -4 lesioned and 4 sham animals-) taken at four anteroposterior levels 
of the DR and MnR. Cell counting was performed manually at the microscope with the 
help of analySIS Software. A Darklite illuminator (Micro Video Instruments Inc, Avon, 
USA) was used to improve the visualization of autoradiographic silver grains and 
 8
capture of dark-field images. Micrography was performed using a digital camera 
(DXM1200 3.0, Nikon) and analySIS Software (Soft Imaging System GmbH, Münster, 
Germany). The figures were prepared for publication using Adobe Photoshop software 
(Adobe, San Jose, USA). Data were statistically analyzed using one-way ANOVA 
analysis (GraphPad Software Inc., San Diego, USA). Significance level was considered 
at p-value (p)<0.05. 
 
3. Results 
The presence of 5-HT2C receptor mRNA in cells of the rat raphe nuclei has been 
examined at four different coronal planes of the DR and MnR, corresponding to -7.1, 
-7.9, -8.6 and -9.1 mm from bregma according to Paxinos and Watson (Paxinos and 
Watson, 1998). A macroscopic view of the localization of 5-HT2C receptor mRNA 
positive cells in the DR and superior portion of MnR at level 44 of atlas of Swanson 
(Swanson, 1998) is illustrated in Fig.1.  
5-HT2C receptor mRNA hybridization signal could be clearly seen as autoradiographic 
grains concentrated over cell profiles in the DR and MnR, as well as in other structures 
of the rat upper pons including the periaqueductal gray, superior and inferior colliculi, 
tegmental nuclei and reticular formation, as shown in Fig. 1. Within the DR, 5-HT2C 
receptor mRNA positive cells were mainly detected in the intermediolateral portion and 
lateral wings (see Figs. 1 and 2A), and only few cells were found in the central aspects 
of the nucleus (including the dorsomedial, ventromedial, interfascicular and caudal 
subnuclei). Two types of cell profiles could be distinguished depending on the density of 
5-HT2C receptor mRNA labeling: strongly labeled and weakly labeled cells, which were 
intermingled in the DR. In the MnR, 5-HT2C receptor mRNA-containing cells were mainly 
located in the lateral zone (Fig. 2B). The majority of them showed a weak hybridization 
signal, but some strongly labeled cells were also seen, confined to the dorsal portion of 
the MnR.  
5-HTT and GAD mRNAs were used as markers of serotonergic and GABAergic cells 
respectively and were detected in tissue sections using either non-radioactive or 
radioactive probes. A large number of 5-HTT mRNA-positive cells were visualized in the 
DR and MnR. Numerous GAD mRNA-containing cells could also be identified in these 
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nuclei, mainly located in the ventrolateral and intermediolateral portions of the DR and in 
the lateral aspects of the MnR as we have recently reported (Serrats et al., 2003a). 
In order to analyze the cellular coexistence of the different mRNAs, we performed 
double-label in situ hybridization experiments on tissue sections from 3 rats taken at four 
anteroposterior anatomical levels of through the DR and MnR. We used 33P-labeled 
oligonucleotides to identify 5-HT2C receptor mRNA and Dig-labeled oligonucleotides to 
detect 5-HTT or GAD mRNAs (Fig. 2C,D). We observed that in the raphe nuclei 5-HT2C 
receptor mRNA and 5-HTT mRNA were expressed in different cell populations. Thus, 
we did not visualize any serotonergic cell expressing detectable levels of 5-HT2C 
receptor mRNA in the anterior raphe nuclei (Fig. 2C). 
In contrast, 5-HT2C receptor mRNA was often found in GAD mRNA-containing cells in 
the DR and MnR (Fig. 2D). In the DR the amount of cells per section that co-expressed 
both mRNAs varied from 33.4 ± 8.5 to 49.3 ± 9.0 (mean ± SEM, n=3), depending on the 
anteroposterior level of nucleus. Still, a substantial number of cells expressing 5-HT2C 
receptor mRNA was devoid of the GABAergic marker (17.3 ± 1.5 to 23.3 ± 0.9 cells per 
section). Although most GABAergic cells in the DR were found to express 5-HT2C 
receptor mRNA (84.32 ± 0.97%), we also detected GAD mRNA-positive cells without 
apparent 5-HT2C receptor mRNA labeling (5.1 ± 2 .4 to 10.1 ± 2.2 cells per section). A 
similar situation was found in the MnR, although the number of cells that co-expressed 
both 5-HT2C receptor and GAD mRNA was lower (23.1 ± 3.5 to 26.8 ± 2.4 cells per 
section, accounting for the 79.00 ± 1.69% of the total number of GAD mRNA positive 
cells). The MnR also contained 5-HT2C receptor mRNA-positive cells devoid of GAD 
mRNA (13.4 ± 3.6 to 24.5 ± 1.5 cells per section) and GAD mRNA cells devoid of 
5-HT2C receptor mRNA signal (2.1 ± 1.2 to 11 ± 2.9 cells per section, depending on the 
anteroposterior level of the MnR).  
 
Effect of 5,7-DHT lesions  
Intracerebroventricular (i.c.v.) injection of 5,7-DHT induced a large depletion of 5-HTT 
mRNA labeling in the DR and MnR (Fig. 3A,A’). Thus, 5-HTT mRNA hybridization signal 
was completely absent in the DR of the lesioned rats, and only a few labeled cells could 
be observed in the most ventral part of the MnR. In contrast, GAD mRNA signal in 
lesioned animals did not differ from sham-operated rats (Fig. 3B,B’). 5-HT2C receptor 
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mRNA-positive cells were still present in the DR and MnR after the lesion (Fig. 3C,C’). In 
the DR of treated rats, particularly in intermediate levels of the nucleus, we observed a 
slight increment in the number of 5-HT2C receptor mRNA positive cells. Thus, the 
average total number of 5-HT2C receptor mRNA-containing cells counted in 4 sections 
was 170.0 ± 5.7 in lesioned rats compared to 141.5 ± 10.6 in sham operated rats. 
However, there were no statistically significant differences between these data. 
 
4. Discussion 
In this study we have visualized the presence of 5-HT2C receptor mRNA in cells of the 
anterior raphe nuclei. Our data basically demonstrate that 5-HT2C receptor mRNA is not 
expressed by serotonergic cells but, in contrast, it is found in the majority of GABAergic 
neurons located within the DR and MnR. Although the existence of 5-HT2C receptor 
mRNA in the anterior raphe nuclei has been described before (Hoffman and Mezey, 
1989; Molineaux et al., 1989; Pompeiano et al., 1994; Wright et al., 1995), the 
phenotype of the cells that express this receptor remained to be determined.   
Cells showing 5-HT2C receptor mRNA hybridization signal were heterogeneously 
distributed within the DR and MnR, and were mainly located in their lateral and 
intermediolateral parts. In contrast, only few 5-HT2C positive cells were found in the 
central portions of the DR, where numerous 5-HT neurons are tightly packed together 
(Steinbusch, 1981) (see also Fig. 3A). Our results are in very good agreement with the 
reported histochemical detection of 5-HT2C receptor–like immunoreactivity in the rat DR 
(Clemett et al., 2000) and are compatible with data from autoradiographic studies using 
[3H]5-HT or [3H]mesulergine, which have shown the presence of moderate labeling of 5-
HT2C binding sites in the raphe region (Pazos and Palacios, 1985). Similarly to the raphe 
nuclei, in most areas of the rat brain there is a good correlation between the anatomical 
distribution of 5-HT2C receptor mRNA, 5-HT2C receptor immunoreactivity and 5-HT2C 
receptor binding sites (Pazos and Palacios, 1985; Hoffman and Mezey, 1989; Molineaux 
et al., 1989; Mengod et al., 1990; Pompeiano et al., 1994; Abramowski et al., 1995; 
Wright et al., 1995; Clemett et al., 2000), suggesting that 5-HT2C receptors are located at 
the level of cell body and/or dendrites.  
In order to determine whether 5-HT2C receptor-bearing cells in the raphe are 
serotonergic or GABAergic, we have examined the cellular localization of 5-HT and 
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GABAergic markers. Since it has been shown that 5-HTT is exclusively expressed by 
5-HT neurons (Rattray et al., 1999), we have taken 5-HTT mRNA as indicator of 
serotonergic phenotype. GABAergic cells were identified as those containing GAD67 
mRNA. Our data on the cellular localization of 5-HTT and GAD mRNAs in the rat raphe 
nuclei are in agreement with published studies. Thus, 5-HTT mRNA hybridization signal 
was very strong in the raphe nuclei, as it has been shown in different species (Fujita et 
al., 1993; Rattray et al., 1994; Charnay et al., 1996; McLaughlin et al., 1996; Bengel et 
al., 1997; Rattray et al., 1999; Serrats et al., 2003a), and in agreement with studies 
using ligand binding autoradiography (Dawson and Wamsley, 1983; D'Amato et al., 
1987), and immunohistochemistry (Sur et al., 1996). The distribution of 5-HTT mRNA-
positive cells observed here is fully comparable to the known location of serotonergic 
cell bodies (Dahlström and Fuxe, 1964; Steinbusch, 1981). On the other hand, we found 
GAD67 mRNA-labeled cell profiles in the ventrolateral and intermediolateral aspects of 
the DR, in the MnR and other cell groups, as we have already reported (Serrats et al., 
2003a). This organization of GAD mRNA labeled cells is identical to that described in 
former studies using in situ hybridization and immunohistochemistry (Nanopoulos et al., 
1982; Mugnaini and Oertel, 1985; Julien et al., 1987; Wang et al., 1992; Feldblum et al., 
1993; Ford et al., 1995). The hybridization signal obtained for GAD and 5-HTT mRNA 
was much stronger than that of 5-HT2C receptor mRNA.  
Our double-label experiments indicate that 5-HT2C receptor mRNA is expressed by 
most GABAergic cells of the anterior raphe nuclei, but not by 5-HTT mRNA positive 
cells. The non-serotonergic nature of 5-HT2C receptor-containing cells is further 
confirmed by the results obtained after i.c.v. administration of 5,7-DHT. Thus, as 
expected, after 14-day survival 5-HT neurons underwent degeneration and 5-HTT 
mRNA was depleted, whereas neither GAD mRNA nor 5-HT2C receptor mRNAs were 
significantly affected, indicating that cells expressing these mRNAs were spared after 
the lesion. Still, we cannot completely rule out the possibility that 5-HT2C receptor mRNA 
might exist in serotonergic cells that lack 5-HTT. It has been reported that some 
populations of 5-HT neurons do not bear the transporter in their axons (Brown and 
Molliver, 2000) but, according to Rattray et al. (1999), putative serotonergic neurons 
devoid of 5-HTT would represent a minor population, accounting for less than 2% of the 
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total. The absence of 5-HTT would render these neurons insensitive to the neurotoxin 
5,7-DHT, and thus no changes would be expected after the lesion in these cells either.  
The presence of 5-HT2C receptor mRNA in GABAergic cells in the raphe nuclei is in 
accordance with electrophysiological data from Liu et al. (2000). By means of 
intracellular recordings, these authors have observed that the application of 5-HT to DR 
slices induces an increase in the frequency of IPSCs in 5-HT neurons. This effect is 
blocked by the GABAA antagonist bicuculline, suggesting an involvement of GABAergic 
neurons, and is partially inhibited by 5-HT2A and 5-HT2C antagonists. Moreover, the 
effect of the 5-HT2A/2C agonist DOI in this experimental model is markedly greater than 
that of 5-HT, which might be explained by a dual action of 5-HT with opposing effects at 
5-HT2A/2C (excitatory) and 5-HT1A (inhibitory) receptors. Thus, taking into account that 
GABA is among the neurotransmitters that control the activity of serotonergic neurons of 
the raphe (Gallager and Aghajanian, 1976), and that there is histochemical evidence 
showing the presence of GABAergic interneurons in the DR and of GABAergic axon 
terminals that establish synaptic contacts with serotonergic neurons (Wang et al., 1992), 
Liu et al. (2000) have proposed the existence of a negative-feedback loop in the raphe 
in which 5-HT collaterals would innervate GABAergic neurons bearing 5-HT1A, 5-HT2A 
and 5-HT2C receptors. These GABAergic neurons in turn would synapse upon 5-HT 
neurons. In addition to the presence of 5-HT2C receptors on DR GABAergic cells 
described here, we have also shown the expression of 5-HT1A mRNA in these cells 
(Serrats et al., 2003b). It still remains to be determined whether these GABAergic 
neurons also express 5-HT2A receptors. 
5-HT2C receptor expression in GABAergic neurons has already been described in 
other brain structures such as the substantia nigra and ventral tegmental area (Eberle-
Wang et al., 1997). It is noteworthy that the situation in these dopaminergic nuclei is 
similar to our observations in the raphe, since 5-HT2C receptor is found in a 
subpopulation of GAD mRNA positive neurons but never in dopamine cells. In line with 
this, it has been observed that 5-HT2C receptor agonists exert inhibitory effects on 
mesocorticolimbic dopaminergic neurons, which are presumably mediated by 
GABAergic interneurons (Di Giovanni et al., 2001). It has been suggested that, thanks to 
their ability to disinhibit the mesolimbic dopaminergic function, 5-HT2C antagonists might 
be useful as antidepressants and in the treatment of negative symptoms of 
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schizophrenia (Di Matteo et al., 2001). In view of the present data, we can also 
speculate that the blockade of 5-HT2C receptors on DR GABA interneurons might be 
used to decrease the GABAergic tone and indirectly increase the firing of 5-HT cells. 
This mechanism might open further possibilities for the use of 5-HT2C antagonists in the 
treatment of depression and can be –at least in part– responsible for the actions of the 
non-selective 5-HT2A/2C antagonist mianserin as a clinically effective antidepressant.  
After 5,7-DHT lesions the number of 5-HT2C receptor mRNA-positive cells in the DR 
did not significantly vary. This is in contrast with data from other authors that reported an 
up-regulation of 5-HT2C receptors in projection areas following different types of 5,7-DHT 
lesions, including increases in 5-HT2C receptor binding in the striatum (Compan et al., 
1998) and cerebral cortex (Blurton and Wood, 1986), increases in 5-HT2C receptor 
immunoreactivity (Sharma et al., 1997) and 5-HT2C receptor-mediated phosphoinositide 
hydrolysis (Conn et al., 1987) in the choroid plexus. It is known that 5-HT2C receptors 
are expressed in all these regions (Pompeiano et al., 1994), and are located 
postsynaptically to 5-HT terminals. These up-regulation phenomena are interpreted as a 
response of 5-HT2C receptors to the depletion of the neurotransmitter subsequent to the 
degeneration of these nerve terminals. Further studies would be necessary to clarify 
whether the lack of 5-HT also induces a process of hypersensitivity of 5-HT2C receptors 
in the DR.  
We have also visualized here 5-HT2C receptor mRNA in cells apparently devoid of 
GAD mRNA. These GAD mRNA-negative, 5-HTT mRNA-negative neurons that contain 
5-HT2C receptor might belong to other cellular types which have been described in the 
raphe nuclei, such as glutamatergic neurons (Gras et al., 2002), neurons containing 
tyrosine hydroxylase (Ochi and Shimizu, 1978; Björklund and Lindvall, 1984; Stratford 
and Wirtshafter, 1990; Kirifides et al., 2001), or enkephalin (Petrusz et al., 1985; Wang 
and Nakai, 1993) but, as discussed above, they might be also, at least in part, 
serotonergic cells that do not express the transporter. It remains to be determined 
whether these 5-HT2C receptor-containing cells are interneurons or projection neurons. 
In summary, this report provides an anatomical evidence to support previous 
electrophysiological results that suggested the localization of 5-HT2C receptor in 
GABAergic neurons of the raphe nuclei (Liu et al., 2000). Thus, we have observed that 
5-HT2C receptor mRNA is expressed in GABAergic neurons of the raphe nuclei and 
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surrounding areas. Moreover, we have detected 5-HT2C receptor mRNA in other types of 
neurons in the DR and MnR, pointing out to a complex regulation of the activity of 
serotonergic neurons through the activation of 5-HT2C receptors of the raphe nuclei. 
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Figures 
 
 
Fig. 1. Macroscopic visualization of 5-HT2C receptor mRNA in the rat raphe nuclei. A is a 
consecutive section to B stained with cresyl violet for anatomical reference. B is a 
dark-field photomicrograph from an emulsion dipped-section from the upper brainstem, 
where numerous cell profiles expressing 5-HT2C receptor mRNA are visualized, in areas 
such as periaqueductal gray (PAG), superior colliculus (SuG), and dorsal (DR) and 
median (MnR) raphe nuclei. Note that in the DR 5-HT2C receptor mRNA signal is 
restricted to lateral aspects of the nucleus, whereas only few positive cells are found in 
its medial parts. Bar = 1 mm. 
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Fig. 2. Cellular visualization of 5-HT2C receptor mRNA in the rat raphe nuclei and co-
localization with phenotype markers. A and B are dark-field photomicrographs showing 
the 5-HT2C receptor mRNA signal in the DR (A) and MnR (B) where the approximate 
limits of the different subnuclear divisions are depicted. Note the absence of labeling in 
the dorsomedial DR (dm) and ventral portion of the central part of the MnR (c MnR). In 
contrast, abundant 5-HT2C receptor mRNA signal can be observed in the 
intermediolateral (iml) aspects and lateral wings (lw) of the DR, lateral part of the MnR 
(lat MnR) and dorsal pole of the central MnR, whereas only relatively sparse labeled 
cells are found in the ventromedial DR (vm). C and D are high-magnification 
photomicrographs from the DR showing the simultaneous detection of two species of 
mRNAs using a 33P-labeled oligonucleotide probe for 5-HT2C receptor mRNA (silver 
grains) and Dig-labeled probes for 5-HTT mRNA (dark precipitate in C) or GAD mRNA 
(dark precipitate in D). White arrowheads point to double labeled cells. White arrows 
point to single Dig-labeled cells. Black arrows point to single 5-HT2C receptor mRNA-
labeled cells. Bar in A = B = 500 µm. Bar in C = D = 50 µm. 
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Fig. 3. Effect of 5,7-dihydroxytryptamine lesions on the expression of 5-HTT, GAD and 
5-HT2C receptor mRNAs in the raphe nuclei. 5-HTT (A), GAD (B) and 5-HT2C receptor 
(C) mRNAs were expressed in sham (vehicle treated) rats. In contrast, 5-HTT mRNA 
expression is completely abolished in DR and only few labeled cells remain in the MnR 
of 5,7-DHT treated rats (A’), while GAD (B’) and 5-HT2C receptor (C’) mRNAs 
hybridization signal is still present in the DR, MnR and surrounding structures. Bar = 500 
µm. 
